The two most-prescribed weight loss medications in America are semaglutide and tirzepatide. Patients ask us daily which one is "better." The honest answer: it depends on what you're solving for. Here's the plain-English comparison.

The one-sentence version

Semaglutide (Ozempic, Wegovy) activates one hormone pathway (GLP-1). Tirzepatide activates two (GLP-1 and GIP). Because tirzepatide hits two receptors, it typically produces greater weight loss, but semaglutide has a longer safety track record and is often the smarter starting point. If you shop by brand rather than molecule, our Wegovy vs Zepbound breakdown covers the same ground under the names you'll see on the box.

How each medication works

Both drugs mimic natural gut hormones that regulate appetite. When you eat, your intestines release GLP-1, which signals your brain that you're full, slows how quickly food leaves your stomach, and improves how your body handles insulin.

How GLP-1 medications work in the body
Both semaglutide and tirzepatide are GLP-1 receptor agonists. Tirzepatide adds a second mechanism.

Semaglutide: one receptor

Semaglutide is a pure GLP-1 receptor agonist — it activates the GLP-1 receptor and nothing else.

Tirzepatide: two receptors

Tirzepatide is a dual agonist: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is another gut hormone that influences insulin sensitivity and, when combined with GLP-1 activation, appears to amplify the appetite-reduction effect.

What the clinical trials show

The best head-to-head data comes from separate large pivotal trials:

Tirzepatide's higher-dose arm produced the largest sustained weight loss ever documented for a non-surgical intervention. But those trial averages don't tell you what you will experience — individual response varies significantly.

Real Regner patient data

Our patients on semaglutide have reported losses from 15 to 50+ lbs. Our tirzepatide patients tend to hit the higher end of that range faster — but with more up-front side effect management during the dose ramp.

Dosing schedules — where they differ

Both are once-weekly injections that titrate up over months.

Semaglutide titration

Semaglutide starts at 0.25mg and steps up every 4 weeks through 0.5mg, 1.0mg, 1.7mg, and 2.4mg (the maximum for weight loss). Most patients settle at 1.0–1.7mg.

Tirzepatide titration

Tirzepatide starts at 2.5mg and steps up every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Most patients settle at 7.5–10mg.

Neither dose progression should be rushed. In our clinic we frequently hold patients at a lower dose if they're getting good results — the goal is sustainable weight loss, not maximizing the medication.

Side effects — practically identical

The side effect profiles overlap almost entirely: nausea, reduced appetite, occasional constipation or diarrhea, transient fatigue during dose steps. GI symptoms are most common in the first weeks of a new dose and typically fade as your body adjusts.

Where tirzepatide differs

Tirzepatide's higher potency can produce slightly more intense side effects during titration, but with weekly physician check-ins we manage that by slowing the ramp when needed. See our side effects guide for how we handle each symptom in clinic.

Cost - depends on dosage needed

Both medications titrate up over months, and price tracks dose. Because tirzepatide steps through more milligrams to reach its ceiling, its cost tends to climb faster than semaglutide's as you move up the schedule. At the higher doses, tirzepatide can run up to roughly 3x what semaglutide would cost at a comparable stage. That gap is the single most common reason a patient who wants tirzepatide asks us about alternatives.

How we keep it affordable

Coverage is the first lever: some commercial plans cover one medication and not the other, so which is "cheaper" for you often comes down to your specific plan. When neither is covered, a compounded tirzepatide alternative, prepared by a licensed pharmacy and monitored the same way as brand-name, is frequently the lower-cost path to the same molecule. We offer a price match guarantee if you find a lower legitimate quote elsewhere, and we tell you the real number before you commit to a schedule.

We also do not push you to the most expensive option by default. If semaglutide is getting you to your goal, there is no clinical reason to pay for tirzepatide's higher ceiling, and we will say so.

How we decide which to prescribe

There's no universal right answer, so we run every patient through the same honest filter during the free consultation rather than defaulting to whichever drug is trending. Our decision factors:

  1. Starting BMI and weight loss goal. Patients with more to lose often benefit from tirzepatide's higher ceiling. If your target is modest and semaglutide can clearly reach it, we do not reach for the stronger molecule just because it exists.
  2. Prior GLP-1 experience. If semaglutide plateaued, tirzepatide is a logical next step, and we restart its titration from the entry dose rather than matching your old milligrams. If a patient tolerated one poorly, we may not try the other in the same class.
  3. Insurance coverage and budget. If one is covered and the other isn't, that's a big practical factor. When neither is covered, we walk through cash-pay and a compounded tirzepatide option so cost never quietly decides your care for you.
  4. Comorbidities and health history. Certain conditions, including a personal or family history of medullary thyroid carcinoma or MEN 2, take a GLP-1 off the table entirely. We assess this during the health-history review before anyone starts.
  5. How closely it will be watched. Both drugs get safer with weekly check-ins, which is how we manage the dose ramp and catch side effects early. The plan we recommend is always the one we can supervise properly, not just the one with the biggest trial number.
Most patients starting from scratch benefit from starting with semaglutide, seeing how their body responds, and moving to tirzepatide later if the results plateau or their goals change.

That step-up approach is deliberate. Dr. Dave built this practice on matching the medication to the patient in front of us, which sometimes means recommending the cheaper, gentler option and revisiting the decision in a few months rather than starting at the top of the dose chart on day one.

The bottom line

Comparison questions

Semaglutide vs tirzepatide, the questions patients actually ask us.

Have a question we didn't cover? See our full FAQ or call us — one of our team will actually answer.

Is tirzepatide stronger than semaglutide?
In head-to-head trial averages, yes: tirzepatide produced greater weight loss. In SURMOUNT-1, tirzepatide averaged about 15% body weight loss at 5mg, 19.5% at 10mg, and 22.5% at 15mg over 72 weeks, while semaglutide averaged about 14.9% at its 2.4mg maximum over 68 weeks in STEP-1. "Stronger" is not the same as "better for you," though. Tirzepatide activates two receptors (GLP-1 and GIP) instead of one, which is why its ceiling is higher, but a patient who responds well to semaglutide and tolerates it easily may never need that extra ceiling. We match the molecule to the person, not to the trial chart.
How long does it take to lose 30 pounds on tirzepatide?
There is no fixed answer, and any clinic that promises one is guessing. In the SURMOUNT-1 trial, weight came off gradually over 72 weeks as the dose stepped up, with the steepest drop in the first several months. For someone whose starting weight makes 30 pounds roughly 10 to 15% of their body weight, reaching that mark commonly takes several months of consistent use at an effective dose, not weeks. Rushing the titration to get there faster usually backfires with worse side effects. We track your trend weekly and hold the dose when the results are already good.
Can you switch from semaglutide to tirzepatide?
Yes, and it is one of the most common transitions we manage. Patients typically switch when semaglutide results plateau or when their goal changes and they want tirzepatide's higher ceiling. The switch is not dose-for-dose: we restart the tirzepatide titration from its 2.5mg entry point rather than matching your old semaglutide dose, because the medications are not interchangeable milligram for milligram. Doing this under weekly physician supervision keeps side effects manageable during the changeover. If cost is part of your decision, a compounded tirzepatide alternative can make the switch more affordable.
Which has fewer side effects, semaglutide or tirzepatide?
Their side effect profiles overlap almost entirely: nausea, reduced appetite, and occasional constipation or diarrhea, most common in the first weeks of each new dose. In practice, tirzepatide's higher potency can make those symptoms slightly more intense during the dose ramp, so semaglutide is often the gentler starting point. Neither drug is inherently "safer" for a given person. What matters more is how carefully the dose is titrated and whether someone is watching your response, which is why our program runs on weekly check-ins that let us slow the ramp the moment symptoms show up.
Should I start with semaglutide or tirzepatide?
For most patients starting from scratch, we recommend beginning with semaglutide, seeing how the body responds, and moving to tirzepatide later if results plateau or goals change. Semaglutide has the longer real-world safety track record and a slightly gentler dose ramp, which makes it a sensible first step. Patients with a higher starting BMI and an aggressive goal sometimes benefit from tirzepatide's higher ceiling out of the gate. There is no universal right answer, which is why the decision belongs in a doctor-supervised GLP-1 therapy program rather than a one-size chart.
Is compounded tirzepatide the same as brand-name tirzepatide?
The active ingredient is the same molecule, tirzepatide, but compounded versions are prepared by a licensed compounding pharmacy rather than the brand manufacturer, which is why they can cost less. Compounded options are only appropriate when prescribed and monitored by a physician who is watching your dose and response. We use them as a lower-cost path for the right patients, not as a shortcut around medical oversight. Our compounded tirzepatide alternative page covers who it fits and how we supervise it.

Still not sure which is right for you? Book a free 15-minute consultation or call (612) 895-7721. Our medical team will review your history, your goals, and your budget, then recommend the medication that actually fits, semaglutide, brand-name tirzepatide, or a compounded tirzepatide alternative.